Baxter alerts users to potential air bubble risk in Duo-Vent IV solution sets
The FDA’s Center for Devices and Radiological Health has issued an early alert about a possible high-risk issue with Baxter’s Duo-Vent intravenous solution sets. The devices may contain air bubbles in the drip chamber and tubing, which could result in air being delivered to patients.
Baxter circulated a letter to customers on June 30 advising them to stop using the affected lots. The letter lists the product code and specific lot numbers that are under review.
Users are instructed to immediately locate, quarantine, and cease use of the identified sets, then arrange for return and replacement through Baxter’s service center or their distributor.
Facilities should forward the notice to nursing, pharmacy, purchasing and risk-management teams to ensure rapid compliance and protect patient safety.
This writeup was produced by pharmadog from original reporting by fda medwatch.
Original headline: “Early Alert: Intravascular Administration Set Issue from Baxter”
read at fda medwatch ↗
comments(0)
5-min edit window · permanent after that